Arcoma Management
Management criteria checks 2/4
Arcoma's CEO is Mattias Leire, appointed in Feb 2023, has a tenure of 3.42 years. directly owns 1.03% of the company’s shares, worth SEK1.24M. The average tenure of the management team and the board of directors is 3 years and 9.5 years respectively.
Key information
Mattias Leire
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.4yrs |
| CEO ownership | 1.0% |
| Management average tenure | 3yrs |
| Board average tenure | 9.5yrs |
Recent management updates
Recent updates
CEO
Mattias Leire (45 yo)
Mr. Mattias Leire is Chief Executive Officer of Arcoma AB from February 2023. He joined the Arcoma AB in 2023. He has extensive experience from leading positions, including many years within Atos Medical....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 3.4yrs | no data | 1.03% SEK 1.2m | |
| Chief Financial Officer | 4.2yrs | no data | 0.021% SEK 25.2k | |
| Chief Operating Officer | 1.5yrs | no data | no data | |
| Global Sales Director | 2.5yrs | no data | no data |
Experienced Management: ARCOMA's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 4.2yrs | SEK 100.00k | 0.49% SEK 588.0k | |
| Director | 16.5yrs | SEK 100.00k | 4.67% SEK 5.6m | |
| Chairman | 9.5yrs | SEK 400.00k | no data |
Experienced Board: ARCOMA's board of directors are considered experienced (9.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/06 17:57 |
| End of Day Share Price | 2026/07/06 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arcoma AB is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hjalmar Jernstrom | DNB Carnegie Commissioned Research |